title: Polyionic vaccine adjuvants: another look at aluminum salts and polyelectrolytes.
abstract: Adjuvants improve the adaptive immune response to a vaccine antigen by modulating innate immunity or facilitating transport and presentation. The selection of an appropriate adjuvant has become vital as new vaccines trend toward narrower composition, expanded application, and improved safety. Functionally, adjuvants act directly or indirectly on antigen presenting cells (APCs) including dendritic cells (DCs) and are perceived as having molecular patterns associated either with pathogen invasion or endogenous cell damage (known as pathogen associated molecular patterns [PAMPs] and damage associated molecular patterns [DAMPs]), thereby initiating sensing and response pathways. PAMP-type adjuvants are ligands for toll-like receptors (TLRs) and can directly affect DCs to alter the strength, potency, speed, duration, bias, breadth, and scope of adaptive immunity. DAMP-type adjuvants signal via proinflammatory pathways and promote immune cell infiltration, antigen presentation, and effector cell maturation. This class of adjuvants includes mineral salts, oil emulsions, nanoparticles, and polyelectrolytes and comprises colloids and molecular assemblies exhibiting complex, heterogeneous structures. Today innovation in adjuvant technology is driven by rapidly expanding knowledge in immunology, cross-fertilization from other areas including systems biology and materials sciences, and regulatory requirements for quality, safety, efficacy and understanding as part of the vaccine product. Standardizations will aid efforts to better define and compare the structure, function and safety of adjuvants. This article briefly surveys the genesis of adjuvant technology and then re-examines polyionic macromolecules and polyelectrolyte materials, adjuvants currently not known to employ TLR. Specific updates are provided for aluminum-based formulations and polyelectrolytes as examples of improvements to the oldest and emerging classes of vaccine adjuvants in use.
authors: PharmAthene, Inc., Annapolis, MD, USA.
authors: Bradford S
authors: 0000-0002-5957-1890
authors: BS
authors: Powell
authors: Institute for Bioscience and Biotechnology Research, University of Maryland, College Park, MD, USA.
authors: Alexander K
authors: 0000-0001-6186-6156
authors: AK
authors: Andrianov
authors: PharmAthene, Inc., Annapolis, MD, USA.
authors: Peter C
authors: 0000-0001-9366-4890
authors: PC
authors: Fusco
keywords: Alum; Aluminum hydroxide; Chitosan; Immunologic adjuvant; Innate immunity; Nalp3 protein; Pattern recognition receptors; Polymers; Polyoxidonium; Polyphosphazene; Toll like receptors
references: Science. 2013 May 31;340(6136):1232910
references: 23723240
references: Curr Opin Immunol. 1997 Feb;9(1):4-9
references: 9039775
references: Trends Immunol. 2010 Mar;31(3):103-9
references: 20153253
references: Semin Immunol. 2013 Apr;25(2):130-45
references: 23850011
references: Nat Rev Immunol. 2011 Nov 04;11(12 ):865-72
references: 22051890
references: J Immunol. 2009 Oct 1;183(7):4403-14
references: 19734227
references: Nat Immunol. 2014 Aug;15(8):738-48
references: 24952504
references: Nature. 2011 Jan 13;469(7329):221-5
references: 21124315
references: FASEB J. 2012 Mar;26(3):1272-9
references: 22106367
references: Pharm Res. 2011 Jan;28(1):58-65
references: 20372988
references: Clin Vaccine Immunol. 2013 Nov;20(11):1659-68
references: 23986317
references: J Control Release. 2014 Jan 10;173:148-57
references: 24188959
references: Cancer Res. 1946 Apr;6:205-16
references: 21018724
references: Vaccine. 2013 Sep 13;31(40):4362-7
references: 23887038
references: Vaccine. 2010 Oct 1;28 Suppl 5:F17-22
references: 20362624
references: Lancet. 1947 Mar 8;1(6443-6445):282-5
references: 20287147
references: J Pharm Sci. 2011 Apr;100(4):1436-43
references: 20960569
references: Vaccine. 2002 Jan 31;20(9-10):1412-20
references: 11818160
references: Immunol Cell Biol. 2004 Oct;82(5):488-96
references: 15479434
references: Proc Natl Acad Sci U S A. 2011 Jul 5;108(27):11169-74
references: 21690334
references: Vaccine. 2004 Dec 16;23(5):693-8
references: 15542192
references: Expert Rev Vaccines. 2013 Jul;12(7):733-46
references: 23885819
references: Acta Paediatr Taiwan. 2006 Jan-Feb;47(1):7-13
references: 17016963
references: Vaccine. 2014 Jan 3;32(2):217-22
references: 24284410
references: Nat Rev Immunol. 2001 Nov;1(2):135-45
references: 11905821
references: Immunity. 2010 Oct 29;33(4):492-503
references: 21029960
references: N Engl J Med. 2011 Mar 3;364(9):852-60
references: 21366476
references: J Invest Dermatol. 2012 Aug;132(8):1955-8
references: 22797299
references: Nat Rev Immunol. 2010 Dec;10(12):826-37
references: 21088683
references: Curr Opin HIV AIDS. 2010 Sep;5(5):409-13
references: 20978382
references: Vaccine. 2011 Nov 28;29(51):9563-72
references: 21906648
references: Antiviral Res. 2002 Aug;55(2):227-78
references: 12103428
references: Ann Intern Med. 2014 Apr 1;160(7):477-83
references: 24687070
references: N Engl J Med. 2013 Nov 28;369(22):2152-8
references: 24283231
references: Curr Opin Immunol. 2010 Feb;22(1):34-40
references: 20149616
references: MMWR Morb Mortal Wkly Rep. 2014 Jun 13;63(23):511-5
references: 24918486
references: Vaccine. 2011 Mar 16;29(13):2461-73
references: 21256188
references: Infect Immun. 2001 Dec;69(12):7695-702
references: 11705950
references: Future Virol. 2014;9(6):565-585
references: 25309617
references: Immunol Today. 1992 Sep;13(9):374
references: 1466755
references: J Infect Dis. 2014 Nov 1;210 Suppl 1:S465-74
references: 25316869
references: Curr Opin Microbiol. 2000 Oct;3(5):445-50
references: 11050440
references: Eur J Dermatol. 2013 Apr 1;23(2):135-41
references: 23238161
references: Eur J Pharm Sci. 2011 Sep 18;44(1-2):32-40
references: 21699977
references: Am J Public Health Nations Health. 1932 Jan;22(1):7-16
references: 18013433
references: Vaccine. 2008 Feb 6;26(6):778-85
references: 18191310
references: Food Drug Law J. 2005;60(2):143-260
references: 16094771
references: Hum Vaccin Immunother. 2015;11(1):91-4
references: 25483520
references: Arch Physiol Biochem. 2012 Oct;118(4):197-203
references: 22385273
references: Biochim Biophys Acta. 2014 Oct;1840(10 ):3153-61
references: 25065288
references: Cell Mol Immunol. 2012 Nov;9(6):434-8
references: 23085951
references: Biotechnol Adv. 2011 May-Jun;29(3):322-37
references: 21262336
references: Immunol Cell Biol. 2014 Jul;92 (6):535-42
references: 24687021
references: Nature. 2008 Jun 19;453(7198):1122-6
references: 18496530
references: Vaccine. 2013 Aug 20;31(37):3979-86
references: 23770306
references: Annu Rev Public Health. 1999;20:211-29
references: 10352857
references: Vaccine. 2007 Jan 26;25(7):1204-13
references: 17140708
references: Curr Opin Immunol. 2009 Jun;21(3):339-45
references: 19493664
references: J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Jun 1;12(2):99-106
references: 8680896
references: Biomacromolecules. 2005 May-Jun;6(3):1375-9
references: 15877355
references: J Leukoc Biol. 2013 Dec;94(6):1167-84
references: 23990626
references: Vaccine. 2011 Dec 30;29 Suppl 4:D7-9
references: 22188929
references: Pharm Biotechnol. 1995;6:249-76
references: 7551220
references: Am J Clin Pathol. 1951 Jul;21(7):645-56
references: 14846770
references: Dev Comp Immunol. 2014 May;44(1):235-44
references: 24384471
references: Eur J Immunol. 2012 Oct;42(10 ):2709-19
references: 22777876
references: Vaccine. 2004 Aug 13;22(23-24):3127-35
references: 15297065
references: Lancet. 2010 Jun 5;375(9730):1969-87
references: 20466419
references: Vaccine. 1998 Jan;16(1):92-8
references: 9607015
references: Vaccine. 2014 May 1;32(21):2420-7
references: 24662707
references: Nat Rev Immunol. 2014 Jul;14 (7):505-14
references: 24925139
references: Front Immunol. 2013 Jan 10;3:406
references: 23335921
references: J Immunol. 2014 Apr 1;192(7):3259-68
references: 24610009
references: Front Immunol. 2014 Feb 03;5:32
references: 24550916
references: Int J Pediatr Otorhinolaryngol. 2012 May;76(5):623-35
references: 22404948
references: ACS Nano. 2013 Dec 23;7(12):10834-49
references: 24261790
references: J Exp Med. 2014 Jun 2;211(6):1019-25
references: 24799501
references: Eur J Pharm Biopharm. 2012 Jan;80(1):25-32
references: 21964315
references: Vaccine. 2010 Apr 19;28(18):3076-9
references: 20193791
references: Bull World Health Organ. 2008 Feb;86(2):140-6
references: 18297169
references: Nature. 1946 Sep 7;158:350
references: 20997597
references: J Hyg (Lond). 1921 Oct;20(2):176-220
references: 20474734
references: J Biomed Biotechnol. 2012;2012:831486
references: 22505817
references: J Pharm Sci. 2012 Sep;101(9):3078-90
references: 22538529
references: Am J Public Health Nations Health. 1934 Jan;24(1):22-4
references: 18013906
references: Vaccine. 2007 Dec 17;25(52):8673-86
references: 18037196
references: Immunol Rev. 2000 Aug;176:154-70
references: 11043775
references: Vaccine. 2013 Oct 1;31(42):4812-9
references: 23933339
references: Vaccine. 2008 Aug 18;26(35):4594-601
references: 18588935
references: Mar Drugs. 2010 Feb 21;8(2):292-312
references: 20390107
references: Pharmacoepidemiol Drug Saf. 2001 Aug-Sep;10(5):403-6
references: 11802585
references: Proc Natl Acad Sci U S A. 2009 Jan 20;106(3):870-5
references: 19139407
references: J Intern Med. 2012 May;271(5):510-20
references: 22026504
references: Biosecur Bioterror. 2004;2(4):281-93
references: 15650438
references: Expert Rev Vaccines. 2013 Nov;12(11):1351-68
references: 24066727
references: Proc Natl Acad Sci U S A. 2014 Aug 26;111(34):12288-93
references: 25136130
references: Dev Biol Stand. 1998;92:79-87
references: 9554261
references: Int Immunopharmacol. 2004 Dec 15;4(13):1615-23
references: 15454114
references: Adv Drug Deliv Rev. 2010 Jan 31;62(1):59-82
references: 19925837
references: Vaccine. 2008 May 23;26(22):2680-8
references: 18430493
references: Nat Med. 2005 Apr;11(4 Suppl):S5-11
references: 15812490
references: Clin Infect Dis. 2002 Jan 1;34(1):84-90
references: 11731951
references: Hum Vaccin. 2011 Jan 1;7(1):58-66
references: 21285531
references: Mol Immunol. 2012 Jul;51(3-4):292-303
references: 22521769
references: Vaccine. 2007 Mar 1;25(11):2085-94
references: 17258843
references: Nat Med. 2011 Apr;17 (4):479-87
references: 21399646
references: Proc (Bayl Univ Med Cent). 2005 Jan;18(1):21-5
references: 16200144
references: Immunol Cell Biol. 2004 Oct;82(5):497-505
references: 15479435
references: Expert Rev Vaccines. 2013 Jul;12(7):723-6
references: 23885817
references: Philos Trans R Soc Lond B Biol Sci. 2013 Jun 24;368(1623):20120137
references: 23798686
references: Pharm Biotechnol. 1995;6:229-48
references: 7551219
references: J Biotechnol. 2012 Dec 31;162(2-3):171-82
references: 22981627
references: Drug Saf. 2013 Jun;36(6):393-412
references: 23637071
references: Vaccine. 2013 Feb 27;31(10):1447-52
references: 23142308
references: Bull World Health Organ. 1969;41(3):617-21
references: 5309486
references: Proc Natl Acad Sci U S A. 2009 Nov 10;106(45):18936-41
references: 19864632
references: Future Microbiol. 2010 May;5(5):749-58
references: 20441547
references: Nat Med. 2013 Dec;19(12):1597-608
references: 24309663
references: Microbes Infect. 2009 Feb;11(2):296-301
references: 19110068
references: Biomacromolecules. 2004 Sep-Oct;5(5):1999-2006
references: 15360316
references: Vaccine. 1984 Mar;2(1):93-9
references: 6397928
references: Expert Rev Vaccines. 2015 Jan;14(1):37-53
references: 25262982
references: Russ J Immunol. 2003 Apr;8(1):53-60
references: 12717555
references: Biomacromolecules. 2006 Jan;7(1):394-9
references: 16398541
references: J Biol Chem. 2011 Aug 5;286(31):27069-80
references: 21628463
references: Microbes Infect. 2003 Dec;5(15):1407-14
references: 14670454
references: Yonsei Med J. 2009 Feb 28;50(1):22-30
references: 19259344
references: Part Fibre Toxicol. 2012 Aug 28;9:34
references: 22929371
references: Int Rev Immunol. 2013 Apr;32(2):209-20
references: 23570316
references: Sci Rep. 2014 Sep 05;4:6287
references: 25190321
references: Biomaterials. 2014 Oct;35(31):8876-86
references: 25023392
references: Vaccine. 2012 Nov 6;30(48):6918-26
references: 22959986
references: Annu Rev Physiol. 2011;73:479-501
references: 21054166
references: Vaccine. 2012 Aug 24;30(39):5761-9
references: 22796139
references: Expert Rev Vaccines. 2013 Jan;12(1):13-30
references: 23256736
references: Infect Immun. 2010 Mar;78(3):994-1003
references: 20028813
references: Vaccine. 2014 Jul 23;32(34):4259-66
references: 24947995
references: Biofactors. 2014 May-Jun;40(3):284-94
references: 24375529